Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
Clinical trial NCT00606086 · COMPLETED
Trial details
- NCT number
- NCT00606086
- Sponsor
- GlobeImmune
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2012-11-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.